ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,803
Screening encounters
3,145
Diagnostic referrals
616
Outstanding pathways
250

Screening pathway

  1. Screening3,145Encounters
  2. Positive finding1,076Documented findings
  3. Referral616Diagnostic referrals
  4. Follow-up705Diagnostic visits
  5. Outcome366Resolved pathways

Stage totals use different units. Pending pathways: 250. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0652 · EXP-0652Synthetic · Site A

Full participant history through 2026-05-16, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-08-17
  4. · Diagnostic referral · EXP-0652-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Appointment coordination
  8. · Barrier documented · Contact difficulty
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Navigation intervention · Coordination support
  12. · Diagnostic visit · Attended
  13. · Diagnosis · Colposcopy · Biopsy collected
  14. · Diagnosis · Histopathology · No high-grade lesion identified
  15. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-05-05
  16. · Follow-up disposition · Resolved · EXP-0652-T-R
  17. · Screening · HPV DNA · Repeat · Prior VIA positive
  18. · Screening result · HPV DNA · HPV not detected · Adequate
  19. · Surveillance · HPV DNA · Surveillance · After clinical assessment

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

2803 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0420 · Expanded synthetic participant 0420Site E — Resource-Constrained Navigation Programme
EXP-0421 · Expanded synthetic participant 0421Site C — Rural Outreach Programme
EXP-0423 · Expanded synthetic participant 0423Site C — Rural Outreach Programme
EXP-0426 · Expanded synthetic participant 0426Site D — Community Engagement Programme
EXP-0427 · Expanded synthetic participant 0427Site A — Urban Referral Hub
EXP-0429 · Expanded synthetic participant 0429Site E — Resource-Constrained Navigation Programme
EXP-0431 · Expanded synthetic participant 0431Site A — Urban Referral Hub
EXP-0433 · Expanded synthetic participant 0433Site B — Peri-Urban Access Programme
EXP-0435 · Expanded synthetic participant 0435Site D — Community Engagement Programme
EXP-0437 · Expanded synthetic participant 0437Site E — Resource-Constrained Navigation Programme
EXP-0438 · Expanded synthetic participant 0438Site C — Rural Outreach Programme
EXP-0439 · Expanded synthetic participant 0439Site A — Urban Referral Hub
EXP-0440 · Expanded synthetic participant 0440Site E — Resource-Constrained Navigation Programme
EXP-0441 · Expanded synthetic participant 0441Site B — Peri-Urban Access Programme
EXP-0442 · Expanded synthetic participant 0442Site C — Rural Outreach Programme
EXP-0443 · Expanded synthetic participant 0443Site C — Rural Outreach Programme
EXP-0444 · Expanded synthetic participant 0444Site B — Peri-Urban Access Programme
EXP-0446 · Expanded synthetic participant 0446Site B — Peri-Urban Access Programme
EXP-0447 · Expanded synthetic participant 0447Site C — Rural Outreach Programme
EXP-0448 · Expanded synthetic participant 0448Site E — Resource-Constrained Navigation Programme
EXP-0449 · Expanded synthetic participant 0449Site E — Resource-Constrained Navigation Programme
EXP-0450 · Expanded synthetic participant 0450Site A — Urban Referral Hub
EXP-0453 · Expanded synthetic participant 0453Site B — Peri-Urban Access Programme
EXP-0454 · Expanded synthetic participant 0454Site D — Community Engagement Programme
EXP-0455 · Expanded synthetic participant 0455Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1281
HPV DNA
1401
Cytology
463

Navigation activity

Barrier documented
529
Contact attempt
906
Navigation intervention
224
Diagnostic booking
758
Diagnostic visit
705

Documented barriers

Contact difficulty
175
Transport difficulty
163
Appointment coordination
191

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.